Advertisement Pharmaceutical Business review -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
September 20, 2024

Hyphens Pharma introduces new eczema hand balm

Hyphens Pharma has launched Ceradan Advanced Hand Balm, a new addition to its skincare range, specifically designed to combat hand eczema.

Continue
The balm uses its unique pH control technology to restore and maintain the skin's natural defenses against inflammation and itch. Credit: Iqbal Nuril Anwar from Pixabay.
September 19, 2024

Azitra’s ATR-04 receives FDA fast track status for treating skin rash

ATR-04 is being developed to address EGFRi-associated skin rash. Credit: Eszter Miller from Pixabay.
September 18, 2024

FDA grants orphan drug status to Papillon Therapeutics’ PPL-001

PPL-001 is a gene-corrected CD34+ hematopoietic stem and progenitor cell (HSPC) therapy. Credit: PublicDomainPictures from Pixabay.

Contracts

August 9, 2024

Bavarian Nordic secures $156.8m US vaccine deal

The vaccine is marketed under various brand names. Credit: Mathurin NAPOLY / matnapo on Unsplash.

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Harbour BioMed, Moderna partner on immunotherapies development

Deals

Deals July 15, 2024

Merck enhances ophthalmology portfolio with EyeBio acquisition

Pharmaceutical Business Review

Biocon signs licensing and supply deal for diabetes drug in Brazil

Q32 Bio concludes merger deal with Homology Medicines

Zuellig Pharma acquires Cialis and Alimta brands from Lilly

Popular

  1. MinervaX collaborates with Wacker Biotech for GBS vaccine production
  2. Novavax announces availability of Covid-19 vaccine in US pharmacies
  3. China NMPA approves Keymed Biosciences’ Stapokibart for atopic dermatitis
  4. ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy
  5. Merck introduces single-use reactor to accelerate ADC manufacturing

PRESS RELEASES

Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: EcoVadis Gold with Further Improved Score
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer: Innovative Silicone Oil-Free Syringe Systems for Sensitive Ophthalmic Drugs
Gerresheimer Remains on Track in First Half of 2024
Gerresheimer Remains on Track in First Half of 2024
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS Joins Meta’s Open Loop Programme to Shape Future of AI Policy
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award
RWS’s Linguistic AI Solution Evolve Wins Prestigious 2024 AI Breakthrough Award

Suppliers

Whitepapers

Saving Through Partnership and Innovation
Saving Through Partnership and Innovation
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Case Study: Exploring Machine Translation in a Global Pharmacovigilance Programme
Wound Care – Selecting the Right Antiseptic for Your Formulation
Wound Care – Selecting the Right Antiseptic for Your Formulation